NNNN
Anbio Biotechnology
6.10$
-3.3%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
Anbio Biotechnology (NNNN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 4.7 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|
| 3.3 | 4.0 | 6.3 | 2.5 | 5.0 | 2.0 | 4.7 | |
| 1.4 | 2.3 | 2.1 | 0.4 | 0.4 | 0.4 | 0.9 | |
| 1.9 | 1.7 | 4.2 | 2.1 | 4.6 | 1.7 | 3.9 | |
| – | 0.1 | 0.1 | 0.4 | 0.1 | 0.0 | 0.1 | |
| 0.4 | 1.1 | 0.3 | 3.9 | 0.9 | 0.5 | 1.1 | |
| 1.5 | 0.6 | 3.9 | -1.7 | 3.7 | 1.2 | 2.8 | |
| 1.6 | 0.8 | 3.9 | -1.3 | 4.1 | 1.3 | 3.0 | |
| 1.6 | 0.8 | 3.9 | -1.3 | 4.1 | 1.3 | 3.0 | |
| 1.5 | 0.8 | 3.9 | -1.3 | 3.7 | – | 2.8 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.